news

Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones

Jan 10, 2025 · Source: cision
Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones

PANAJI, India, Jan. 10, 2025 -- Zlata Pharma LLP hosted a memorable event to mark the launch of its new wellness product range, marking a significant milestone. At the heart of the evening was the shared vision of positioning Goa prominently on India's pharmaceutical map, with a mission to establish Zlata Pharma as a key player in the healthcare sector over the next 3–5 years. Zlata Pharma's unveiling of its new product range marked a significant milestone.

The products include Pain Relief, a Balm for headaches and colds, a Spray for targeted relief on the back, neck, and joints, and a Gel for sprains and body aches. Additionally, Zlata is entering the Sexual Wellness category with the launch of Sambhog. As the company expands its footprint into new categories, Zlata will remain its flagship brand, embodying innovation and excellence in the healthcare sector.

The occasion was graced by Dr. Shri Shekhar Salkar, MS. FICS ONCO, along with Dr. Tarak Arolkar, Chairman, Zlata Pharma LLP, Mr. Harshad Sadvelkar, Managing Director, Zlata Pharma LLP, Mr. Rajesh Dalvi, Chief Executive Officer, Zlata Pharma, Mr. Amit Falari, Chief Finance Officer and Mr. Pratap Naik, Chief Operating Officer participated in a ceremonial lamp-lighting, embodying hope and the power of collective action.

Dr. Shri Shekhar Salkar, MS. FICS ONCO, praised Zlata Pharma's commitment to innovation and healthcare excellence Zlata Pharma's dedication to merging traditional wisdom with modern science is truly commendable. Their Pain Relief Range, reflects an unwavering commitment to improving lives across India. It is heartening to see a company born in Goa stepping forward with such innovation and purpose, creating solutions that resonate with the needs of millions. I am confident that Zlata Pharma will continue to set benchmarks in healthcare, making a meaningful impact not just in the state, but nationwide."

Shri Harshad Sadvelkar, Managing Director of Zlata Pharma, shared his excitement for the future. "We are incredibly excited about the future and the immense opportunities ahead. At Zlata Pharma, we are deeply committed to positioning Goa as a central hub for pharmaceutical innovation and cutting-edge research. Our goal is to not only generate high-quality employment across India but also to build a workforce that is as passionate and driven as we are. Our success will be measured by the impact we make on the healthcare sector and our ability to serve communities with trustworthy and effective solutions. This is not just a business initiative; it is a commitment to contributing meaningfully to India's healthcare landscape. As we grow, we aim to create a sustainable legacy that empowers both Goa and the nation."

Chairman of Zlata Pharma LLP Shri Tarak Arolkar stated, "Our journey is just beginning, and while the road ahead is full of challenges, our aspirations are clear and unwavering. Zlata Pharma is driven by a mission to make a real difference in the pharmaceutical industry, in Goa, and in the lives of those who place their trust in us. Our vision is one of long-term growth, where we continue to innovate and lead with purpose. Goa is not just where we do business – it's our home, our foundation, and the source of our values. As we look to expand nationally and globally, we are committed to staying true to our roots and building a company that reflects the spirit of this great state, while contributing to the broader healthcare narrative. We believe that our success will ultimately be a success for Goa, for India, and for all those who stand with us."

The gathering beautifully blended cultural pride, a commitment to innovation, and a shared vision of shaping a brighter future for the healthcare industry. As the guests lingered over conversations and a sumptuous dinner, one thing was clear – Zlata Pharma's launch was not just a milestone for the company but a step toward building a legacy that combines innovation, opportunity, and human connection. With its strong roots in Goa and a vision to impact healthcare on a national scale, Zlata Pharma is poised to not only make a mark in the industry but also inspire a sense of pride and purpose for the community it calls home.

About Zlata Pharma LLP

Zlata Pharma LLP, a newly incorporated company based in Goa, founded by a team of seasoned Goan industry professionals ventured into the highly competitive and fast-growing Pain Relief Category. The management is excited to announce the launch of its latest Pain Relief Range, composed to relieve millions of Indians from aches and pains of multiple types. This new product brings the age-old, tried and tested goodness of exceptional quality, and reliable relief. Zlata will be the flagship brand of the company going forward, as it expands its footprint into new categories.

Photo: https://mma.prnewswire.com/media/2595479/Product_Launch_Zlata_Pharma_LLP.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/goa-to-lead-in-pharma-growth-as-zlata-pharma-sets-industry-milestones-302348010.html

Comments (0)

Login to join the conversation

Login / Register

No comments yet. Be the first to comment!

More to Read

Aarti Industries Delivers Promising Q1 FY27; Reaffirms Long-Term Growth Outlook
news
Jul 30, 2026 1 min

Aarti Industries Delivers Promising Q1 FY27; Reaffirms Long-Term Growth Outlook

MUMBAI, India , July 30, 2026 -- Aarti Industries Limited (AIL), a leading global speciality chemicals company, today announced its consolidated financial results for the first quarter ended June 30, 2026. The results were approved by the Board of Directors at its meeting held earlier today. The Company delivered a strong start to FY27, reporting approximately 79% year-on-year and 13% quarter-on-quarter EBITDA growth, driven by an optimised product mix, inventory, and forex gains despite volume degrowth in a challenging global operating environment.

SEMI Announces New Spring Schedule for SEMICON West Beginning March 30-April 1, 2027
news
Jul 30, 2026 1 min

SEMI Announces New Spring Schedule for SEMICON West Beginning March 30-April 1, 2027

Phoenix to Become the Long-term Home of North America s Premier Semiconductor Industry Event MILPITAS, Calif. , July 30, 2026 -- SEMI , the global industry association serving the semiconductor and electronics design and manufacturing supply chain, today announced a significant evolution for SEMICON West , establishing a new annual spring schedule beginning March 30 April 1, 2027, at the Phoenix Convention Center in Phoenix, Arizona.

Elevated Materials Strengthens Commercial Leadership with Appointment of Jay Wang as Chief Revenue Officer
news
Jul 30, 2026 1 min

Elevated Materials Strengthens Commercial Leadership with Appointment of Jay Wang as Chief Revenue Officer

Jay Wang brings global commercial leadership across semiconductors, LEDs, and advanced battery markets as Elevated Materials expands customer adoption of its ultra-thin lithium films. SANTA CLARA, Calif. , July 30, 2026 -- Elevated Materials, a leading manufacturer of ultra-thin lithium films for next-generation batteries, today announced the appointment of Jay Wang as Chief Revenue Officer. Jay brings more than two decades of global sales, business development, and general management experience across battery, semiconductors, LEDs, and advanced technology markets. He has led commercial organizations across Asia and the United States, building high-performing teams, expanding customer relationships, and driving revenue growth across automotive, consumer electronics, AI, networking, IoT, and industrial markets.

Frost & Sullivan Marks 65 Years of Identifying ICT Growth Opportunities
news
Jul 30, 2026 1 min

Frost & Sullivan Marks 65 Years of Identifying ICT Growth Opportunities

Deep sector expertise and AI-powered intelligence help organizations turn technological disruption into growth LONDON , July 30, 2026 -- As Frost & Sullivan celebrates its 65th anniversary, the company is reflecting on its long-standing role in helping organisations anticipate technological change, navigate disruption and identify transformational growth opportunities across the information and communications technology (ICT) landscape.

NYSE Content Update: Jersey Mike's Raises $1 Billion Ahead of NYSE Debut
news
Jul 30, 2026 1 min

NYSE Content Update: Jersey Mike's Raises $1 Billion Ahead of NYSE Debut

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK , July 30, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today s NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on July 30th Jersey Mike s Subs (NYSE: JMKE) and Reformation (NYSE: REF) will begin trading on the NYSE today following their respective IPOs. Jersey Mike s offers more than 43 million shares at 23 a piece. Jersey Mike s CEO Charlie Morrison will join NYSE Live to discuss the firm s next move after going public. Reformation raises 211 million in its Initial Public Offering. Investors are dissecting Wednesday s policy decision from the Federal Reserve and parsing through fresh earnings data.

DXC Announces Leadership Appointments to Accelerate Its AI-Centric Future
news
Jul 30, 2026 1 min

DXC Announces Leadership Appointments to Accelerate Its AI-Centric Future

Paul Taylor named President of DXC; Dan Gray to lead Global Infrastructure Services ASHBURN, Va. , July 30, 2026 -- DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, today announced a series of leadership appointments effective immediately that position the next generation of AI-centric leadership at the forefront of the company and further streamline the organization for customers, partners, and employees. Paul Taylor has been named President of DXC Technology, assuming the role from Raul Fernandez, who continues as Chief Executive Officer. In addition, Dan Gray has been appointed President of Global Infrastructure Services (GIS). Ramnath Venkataraman, President of Consulting & Engineering Services (CES), and Ray August, President of Insurance Software & Business Process Services (ISB), will continue to lead their businesses, with all three offering presidents reporting to Taylor. Chris Drumgoole, currently President of GIS, will depart DXC to take on an elevated leadership role outside the company and will join as a founding member of DXC s newly formed CEO Advisory Council.

How Dubai Successfully Turned the Summer Break into a Platform for Prevention and Positive Youth Development
news
Jul 30, 2026 1 min

How Dubai Successfully Turned the Summer Break into a Platform for Prevention and Positive Youth Development

DUBAI, UAE , July 30, 2026 -- Rather than viewing the summer break as time away from learning, Dubai has turned it into an opportunity to strengthen prevention, discipline, safety awareness and positive values among young people through Dubai Police s Hemaya International Centre. This year, the centre s Summer Student Programme graduated 1,402 students from 31 nationalities, bringing the total number of graduates since 2018 to 10,792 students representing 175 nationalities.

WEKA and Andromeda Partner to Power AI Workloads at Global Scale
news
Jul 30, 2026 1 min

WEKA and Andromeda Partner to Power AI Workloads at Global Scale

Partnership delivers consistent, high-performance AI storage across Andromeda s global provider network, lowering the total cost of innovation for AI teams CAMPBELL, Calif. , July 30, 2026 -- WEKA , the AI data and memory infrastructure company, today announced that Andromeda , the platform connecting AI teams with high-performance compute, is integrating the WEKA NeuralMesh platform as a core AI data storage layer for managed GPU clusters. Andromeda s customers can now access a dedicated NeuralMesh or a GPU-native WEKA NeuralMesh Axon deployment to achieve consistent storage performance across any cluster running on any hyperscaler or AI cloud.